Globally, Versius is the second most utilized surgical robotic system, withover26,000 surgical procedures completed across Europe, Latin America, Asia, Middle East and Africa With its unique compact ...
Strong clinical interest received from US surgeons nationwide for the system CMR Surgical, a global medical technology company, today announces its second-generation surgical robotic platform, Versius ...
The U.S. FDA recently cleared Medtronic plc’s Hugo robotic-assisted surgery system and CMR Surgical Ltd.’s Versius Plus ...
Versius customer reach increases as CMR Surgical closes 2023 with strongest quarter on record After a record quarter, CMR closes the year with a Versius global install base more than 50% higher than ...
CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...
CMR Surgical launches vLimeLite * a new imaging technology to visualise ICG, the first product launch in a series of 2024 product releases as part of Versius Plus, a significant enhancement to the ...
CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system Regulatory clearance of CMR's most advanced system paves the way for upcoming US commercial launch Strong clinical ...
Regulatory clearance of CMR’s most advanced system paves the way for upcoming US commercial launch Strong clinical interest received from US surgeons nationwide for the system CMR Surgical, a global ...